{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:00:36Z","timestamp":1757624436537,"version":"3.44.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010882","name":"Australasian Society of Clinical Immunology and Allergy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.jacig.2023.100080","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T22:54:24Z","timestamp":1675810464000},"page":"100080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A\u00a0review of recent Canadian real-world literature"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6787-1589","authenticated-orcid":false,"given":"Uliana","family":"Kovaltchouk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Jeimy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianne","family":"Soller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elissa M.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott B.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2023.100080_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13223-018-0282-5","article-title":"Allergen-specific immunotherapy","volume":"14","author":"Moote","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100080_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2015.12.1298","article-title":"Sublingual or subcutaneous immunotherapy for allergic rhinitis?","volume":"137","author":"Durham","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100080_bib3","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/all.13201","article-title":"Allergen immunotherapy for allergic rhinoconjunctivitis: a systemic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2023.100080_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ACI.0000000000000335","article-title":"Allergen immunotherapy: an updated review of safety","volume":"17","author":"James","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100080_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13223-020-00491-5","article-title":"A single centre retrospective study of systemic reactions to subcutaneous immunotherapy","volume":"16","author":"Robertson","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100080_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13223-021-00566-x","article-title":"Systemic reactions to subcutaneous allergen immunotherapy: real-world cause and effect modelling","volume":"17","author":"Aue","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100080_bib7","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacig.2023.100080_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2500\/aap.2019.40.4228","article-title":"Current management and use of oral immunotherapy in the United States for patients with peanut allergy","volume":"40","author":"Blaiss","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jacig.2023.100080_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaip.2014.06.023","article-title":"Allergist-reported trends in the practice of food allergen oral immunotherapy","volume":"3","author":"Greennhawt","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100080_bib10","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.jaip.2020.12.025","article-title":"A high proportion of Canadian allergists offer oral immunotherapy but barriers remain","volume":"9","author":"Mack","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"20","key":"10.1016\/j.jacig.2023.100080_bib11","article-title":"CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy","volume":"16","author":"Begin","year":"2020","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100080_bib12","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100080_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/pai.13447","article-title":"Impact of age on adherence and efficacy of peanut oral-immunotherapy using a standardized protocol","volume":"32","author":"Zhu","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jacig.2023.100080_bib14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaip.2018.05.023","article-title":"Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients","volume":"7","author":"Wasserman","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100080_bib15","first-page":"CD010638","article-title":"Oral and sublingual immunotherapy for egg allergy","volume":"4","author":"Romantsik","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacig.2023.100080_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.anai.2019.06.021","article-title":"Systemic reactions to subcutaneous immunotherapy: effects of dosing and aeroallergen content","volume":"123","author":"Mustafa","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2023.100080_bib17","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jaip.2019.01.058","article-title":"AAAI\/ACAAI subcutaneous immunotherapy surveillance study (2013-2017): fatalities, infections, delayed reactions, and use of epinephrine autoinjectors","volume":"7","author":"Epstein","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100080_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaci.2019.09.011","article-title":"Three-year follow up after peanut food challenges: accidental reactions in allergic children and introduction failure in tolerant children","volume":"145","author":"Kansen","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100080_bib19","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.jaip.2021.01.038","article-title":"Community use of epinephrine for the treatment of anaphylaxis: a review and meta-analysis","volume":"9","author":"Miles","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100080_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2009.08.028","article-title":"Food allergy","volume":"125","author":"Sicherer","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100080_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12889-017-4594-z","article-title":"Parents\u2019 and caregivers\u2019 experiences and behaviours when eating out with children with a food hypersensitivity","volume":"18","author":"Begen","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacig.2023.100080_bib22","doi-asserted-by":"crossref","first-page":"49-64","DOI":"10.1177\/1359104511415636","article-title":"A qualitative investigation into the maternal experience of having a young child with severe food allergy","volume":"17","author":"Rouf","year":"2012","journal-title":"Clin Child Psychol Psychiatry"},{"key":"10.1016\/j.jacig.2023.100080_bib23","doi-asserted-by":"crossref","first-page":"255-66","DOI":"10.1177\/1742395311411591","article-title":"A qualitative study of families of a child with a nut allergy","volume":"7","author":"Pitchforth","year":"2011","journal-title":"Chronic Illn"},{"key":"10.1016\/j.jacig.2023.100080_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11882-019-0862-6","article-title":"GRADE-ing the benefit\/risk equation in food immunotherapy","volume":"19","author":"Duca","year":"2019","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jacig.2023.100080_bib25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/all.14072","article-title":"The value of oral immunotherapy","volume":"75","author":"Dufresne","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2023.100080_bib26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1398-9995.2010.02342.x","article-title":"The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review","volume":"65","author":"Cummings","year":"2010","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277282932300005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277282932300005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:10:44Z","timestamp":1757423444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277282932300005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S277282932300005X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2023.100080","relation":{},"ISSN":["2772-8293"],"issn-type":[{"type":"print","value":"2772-8293"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A\u00a0review of recent Canadian real-world literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2023.100080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100080"}}